Clinical Trials Directory

Trials / Completed

CompletedNCT03279536

Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
99 (actual)
Sponsor
Woman's Health University Hospital, Egypt · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This study consisted of 60 cases. All the cases of pregnant women are 4 months to 8 months of pregnancy. The cases divided into 30 pregnant women's were given iron supplementation without health education and another 30 were given iron supplementation and health education for comparison between them. Comparative between hemoglobin levels before and after medication. Treatment of iron deficiency anemia with iron supplementation received for one month.

Detailed description

The investigator will divide the participants into two groups e.g. group (A) and group (B) according to Hemoglobin level and receiving of oral supplementation for IDA accompanied with health education in case of group (A) and without health education in case of group (B). Then the investigator asked patient to sign the document of her investigations result to receive iron supplementation. * After that, the investigator observes hemoglobin's Level, when it less than \>11g/dl, the patient will be the group (A) who will receive oral iron supplementation and health education. * Group (B) who will receive Total Dose Infusion (TDI) without health education.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTOral lactoferrinOral lactoferrin 120 mg twice /day and it's based on fast dissolving through direct swallowing per oral route with fruits flavor taste.
COMBINATION_PRODUCTTDI of LMW iron dextranTotal Dose Infusion of LMW iron dextran up to 20mg/kg body weight is infused intravenously

Timeline

Start date
2017-11-01
Primary completion
2018-12-30
Completion
2018-12-30
First posted
2017-09-12
Last updated
2020-10-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03279536. Inclusion in this directory is not an endorsement.